Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.
- DOI
- 10.1016/j.jpet.2026.104301
- Published
- 2026 Apr
- Container
- The Journal of pharmacology and experimental therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpet.2026.104301,
title = {Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.},
author = {Comanzo CG and Buatti Fagalde F and Vera MC and Oviedo Bustos L and Palma NF and Capiglioni AM and Hesse L and Pisani GB and Ferretti AC and Ceballos MP and Alvarez ML and Quiroga AD},
year = {2026},
journal = {The Journal of pharmacology and experimental therapeutics},
doi = {10.1016/j.jpet.2026.104301},
url = {https://doi.org/10.1016/j.jpet.2026.104301}
}RIS
TY - JOUR TI - Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment. AU - Comanzo CG AU - Buatti Fagalde F AU - Vera MC AU - Oviedo Bustos L AU - Palma NF AU - Capiglioni AM AU - Hesse L AU - Pisani GB AU - Ferretti AC AU - Ceballos MP AU - Alvarez ML AU - Quiroga AD PY - 2026 JO - The Journal of pharmacology and experimental therapeutics DO - 10.1016/j.jpet.2026.104301 UR - https://doi.org/10.1016/j.jpet.2026.104301 ER -
APA
CG, C., F, B. F., MC, V., L, O. B., NF, P., AM, C., L, H., GB, P., AC, F., MP, C., ML, A., & AD, Q. (2026). Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.. The Journal of pharmacology and experimental therapeutics. https://doi.org/10.1016/j.jpet.2026.104301
Source records
- pubmed · retrieved 2026-09-26T12:06:48.284Z